Validating the impact of a molecular subtype in ovarian cancer on outcomes: A study of the OVCAD Consortium

Most patients with epithelial ovarian cancer (EOC) are diagnosed at advanced stage and have a poor prognosis. However, a small proportion of these patients will survive, whereas others will die very quickly. Clinicopathological factors do not allow precise identification of these subgroups. Thus, we...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Sci
Auteurs principaux: Pils, Dietmar, Hager, Gudrun, Tong, Dan, Aust, Stefanie, Heinze, Georg, Kohl, Maria, Schuster, Eva, Wolf, Andrea, Sehouli, Jalid, Braicu, Ioana, Vergote, Ignace, Cadron, Isabelle, Mahner, Sven, Hofstetter, Gerda, Speiser, Paul, Zeillinger, Robert
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2012
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659264/
https://ncbi.nlm.nih.gov/pubmed/22497737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02306.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires